FMS co., Ltd (XKON:A278990) signed a contract to acquire DM Bio from Dongseup Kim and Jonghak No for approximately KRW 880 million on April 25, 2018. Under the terms of transaction, FMS co., Ltd will issue 2.67108 new shares for every one shares of DM Bio. FMS co., Ltd will issue 0.21 million new shares. Upon completion, DM Bio will be dissolved and FMS co., Ltd will be the surviving company. For the year ended December 31, 2017, DM Bio had total assets of KRW 1.3 billion, net assets of KRW 854.2 million, sales of KRW 500.6 million and net profit of KRW 286.6 million. The head office of FMS co., Ltd will change from 76, Deokcheon-ro 72beon-gil, Manan-gu, Anyang-si, Gyeonggi-do, Republic of Korea to 38, Deokcheon-ro, Manan-gu, Anyang-si, Gyeonggi-do, Republic of Korea. The transaction was approved by the Board of Directors of FMS co., Ltd at the meeting held on May 25, 2018. The transaction is expected to be completed by June 30, 2018.